Cargando…
New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2
The development of specific drugs against SARS-CoV-2 infection is a major challenge facing global science and healthcare. Despite numerous attempts, there are still no truly effective drugs. Currently, the main approach in the creation of drugs against COVID-19 is repurposing, i.e., re-profiling exi...
Autores principales: | Maslova, A. A., Matyugina, E. C., Shustova, E. Yu., Volok, V. P., Kozlovskaya, L. I., Kochetkov, S. N., Khandazhinskaya, A. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165921/ https://www.ncbi.nlm.nih.gov/pubmed/35693979 http://dx.doi.org/10.1134/S0026893322030098 |
Ejemplares similares
-
Synthesis in Escherichia coli cells and characterization of the active exoribonuclease of severe acute respiratory syndrome coronavirus
por: Chen, P., et al.
Publicado: (2009) -
Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2
por: Matyugina, E. S., et al.
Publicado: (2021) -
Fabrication of hydrophobic PLA filaments for additive manufacturing
por: Rajakaruna, Rajakaruna A. D. N. V., et al.
Publicado: (2022) -
Novel dopamine-modified cellulose acetate ultrafiltration membranes with improved separation and antifouling performances
por: Ma, Xi, et al.
Publicado: (2022) -
Large tuning in the electrowetting behaviour on ferroelectric PVDF-HFP/Teflon AF bilayer
por: Wadhai, Sandip M., et al.
Publicado: (2021)